Therefore, all those indazole-based scaffolds had to be fully tested for their physicochemical properties, tolerability, cell cycle arrest, and apoptosis induction capabilities to allow affording more potent and selective FLT3 inhibitors against different FLT3 overexpressing AML cells with higher. This evidence concerns the gene FLT3 and acute myeloid leukemia.